Live Breaking News & Updates on Geron Corporation Nasdaq|Page 1

Stay updated with breaking news from Geron corporation nasdaq. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia

Approval across ESA ineligible and ESA relapsed/refractory patients with LR-MDS with transfusion-dependent anemia, regardless of ring sideroblast status

Durable and sustained red blood cell. ....

Johna Scarlett , Drug Administration , Exchange Commission , Geron Corporation Nasdaq , Malignant Hematology Department , Moffitt Cancer Center , Patient Support Program , Geron Corporation , Chief Executive , Rami Komrokji , Vice Chair , Conference Call , Eastern Time , Prescribing Information , Medication Guide , Private Securities Litigation Reform Act , Myelodysplastic Syndromes , Emerging Therapeutic , Cancer Manag ,

Geron Announces FDA Approval of RYTELO (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia

07.06.2024 - Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that the U.S. Food and Drug Administration (FDA) has approved RYTELO (imetelstat) for the . Seite 1 ....

Johna Scarlett , Geron Corporation Nasdaq , Drug Administration , Geron Corporation , Chief Executive ,

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FOSTER CITY, Calif. (BUSINESS WIRE) May 16, 2024 ....

United States , Communicationskristen Kelleher , Aaron Feingold , Geron Corporation , Drug Administration , Geron Corporation Nasdaq , European Union , Nasdaq Listing Rule , Award Plan , Nobel Prize Winning , New Drug Application , United States Food , Prescription Drug User Fee Act , Investor Relations , Corporate Communicationskristen , Business Wire ,

Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights

June 16, 2024 PDUFA date for imetelstat NDA for the treatment of transfusion-dependent anemia in adult patients with lower-risk MDS

. ....

Johna Scarlett , Geron Corporation Nasdaq , Clinical Development , Exchange Commission , European Medicines Agency , Drug Administration , Geron Corporation , New Drug Application , Chief Executive , Fast Track , Nobel Prize Winning , Prescription Drug User Fee Act , Marketing Authorization Application , Private Securities Litigation Reform Act , Months Ended March ,

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Aaron Feingold , Kristen Kelleher , European Union , Drug Administration , Corporate Communications , Geron Corporation , Geron Corporation Nasdaq , Nasdaq Listing Rule , Award Plan , Nobel Prize Winning , New Drug Application , United States Food , Prescription Drug User Fee Act , Investor Relations ,